Astor
(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 60823.
Registration
- Applicants
- 1
- Registrations
- 4
- Schedule source
- SAHPRA documentation
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Astor 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10/20/40/80 mgFilm-coated tablets | 44105444/7.5/1054Approved 30 September 2025 | Registered | S4 | PIPIL |
| Astor 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 10/20/40/80 mgFilm-coated tablets | 44105544/7.5/1055Approved 30 September 2025 | Registered | S4 | PIPIL |
| Astor 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 10/20/40/80 mgFilm-coated tablets | 44105644/7.5/1056Approved 30 September 2025 | Registered | S4 | PIPIL |
| Astor 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 10/20/40/80 mgFilm-coated tablets | 44105744/7.5/1057Approved 30 September 2025 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Atorvastatin
S4: Atorvastatin
Consolidated Schedules 06 July 2026, line 5376
S4: Ezetimibe
Consolidated Schedules 06 July 2026, line 6302
Pharmacological class: Serum-cholesterol reducers. (class 7.5)
Matched through the component Ezetimibe.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
Schedule Verification
Astor 10, Teva Pharmaceuticals (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.